-

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace.

Specifically, Agilent ranked No. 83 out of 500 companies on Forbes’s 2021 list of America’s Best Employers for Diversity.

The rating was based on dimensions of diversity including gender, ethnicity, LGBTQ+, age, and the differently abled.

Agilent CEO Mike McMullen said he was proud of the recognition – not only because Agilent was ranked in the top 100, but also because the achievement relates to diversity, an essential component of Agilent’s values.

“We are committed to infusing diversity and inclusion into every aspect of how Agilent does business,” McMullen said. “While there is always room for improvement, we’re excited that our good work thus far is being recognized inside and outside the company.”

Forbes based its rankings on an anonymous survey of more than 50,000 U.S. employees at companies that have at least 1,000 U.S.-based employees. Agilent was not involved in any aspect of the survey.

Agilent’s top-100 ranking is a rewarding indication of how well its efforts are being received by employees, said Dominique Grau, Agilent’s vice president of human resources.

“We strive to foster a workplace where all employees can feel comfortable being their true selves,” Grau said. “I’m thrilled by what our ranking says about how aligned our employees are with the journey we are taking.”

Agilent has implemented several initiatives to strengthen diversity and inclusion – especially within the last year.

For example, in the wake of national social unrest in 2020, McMullen held listening sessions with Black employees and helped establish a networking group for Black employees in the U.S.

The company also sponsored events including a Women in Engineering forum in Silicon Valley and a mentorship program for Indigenous students in Australia.

Last year, Agilent also hired Patrice Jimerson, a diversity practitioner with 25 years of experience, to lead its diversity and inclusion program.

“Our people are our strength, and we are strongest when we all contribute our unique and individual perspectives,” Jimerson said. “Agilent is committed to investing the resources we need to do an even better job. I am excited to lead that journey.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Tom Beermann
Agilent Technologies
+1 408-553-2914
tom.beerman@agilent.com

Agilent Technologies Inc. Logo
Agilent Technologies Inc. Logo

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Tom Beermann
Agilent Technologies
+1 408-553-2914
tom.beerman@agilent.com

More News From Agilent Technologies Inc.

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company’s products, operations, and customer workflows. “AI is a top priority, and this partnership reflects both our ambition and our execution commitment — to build the enduring capability, operating model, and capacity required to consistently deliver AI‑driven innovation...

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the expanded use of PD-L1 IHC 22C3 pharmDx, Code GE006, for use on the Dako Omnis platform to aid in identifying patients in the United States with esophageal squamous cell carcinoma (ESCC)3, triple-negative breast cancer (TNBC)4, cervical cancer5, and gastric or gastroesophageal junction (GEJ) adenocarcinoma6, who may be eligible for treatment...
Back to Newsroom